Spectral AI, Inc.MDAI
Price (close)
$1.62
Market cap
$52.1M
P/E
—
Revenue (TTM)
$15.4M
Net income
-$10.1M
Dividend yield
—
1-year total return
-24.7%
Net margin
-65.5%
Revenue growth
-44.1%
Debt / equity
—
What Spectral AI, Inc. does.
on predictive medical diagnostics. Our DeepView System uses proprietary AI algorithms to distinguish between fully damaged, partially
damaged and healthy human tissue characters invisible to the naked eye, at the initial time point of wound presentation. The DeepView
System delivers a binary prediction on the wound’s capacity to heal or not-heal by a specified time point in the future. Our DeepView
Revenue and profit, by fiscal year.
| Fiscal year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | — | — | $25.4M | $18.1M | $29.6M | $19.6M |
| Net income | — | -$2.1M | -$2.9M | -$20.9M | -$15.2M | -$7.6M |
More on MDAI.
- Spectral AI, Inc. summary
- Spectral AI, Inc. financial statements
- Spectral AI, Inc. key metrics
- Spectral AI, Inc. health scores and style box
- Spectral AI, Inc. earnings
- Spectral AI, Inc. dividends
- Spectral AI, Inc. valuation
- Spectral AI, Inc. ownership and insiders
- Spectral AI, Inc. peers
Figures from Spectral AI, Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.